Obstetrics and Gynecology International
Volume 2009 (2009), Article ID 359457, 8 pages
doi:10.1155/2009/359457
Research Article

The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds

Daniel Ndisang,1 Felipe Lorenzato,2 Michael Sindos,1 Ashfaq Khan,1,3 Albert Singer,3 and David S. Latchman1,4

1Medical Molecular Biology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK
2Instituto Materno Infantil de Pernambuco (IMIP), Rua dos coelhos, 300 Boa Vista Recife 1393, Pernambuco, Brazil
3Department of Women's and Children's Health, The Whittington Hospital, Highgate Hill, London N19 5NF, UK
4Birkbeck, University of London, Malet Street, London WC1E 7HX, UK

Received 4 September 2009; Revised 27 December 2009; Accepted 29 December 2009

Academic Editor: Michelle A. Williams

Copyright © 2009 Daniel Ndisang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Daniel Ndisang, Felipe Lorenzato, Michael Sindos, Ashfaq Khan, Albert Singer, and David S. Latchman, “The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds,” Obstetrics and Gynecology International, vol. 2009, Article ID 359457, 8 pages, 2009. doi:10.1155/2009/359457